サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1362891

臨床試験マッチングソフトウェアの市場規模、シェア、動向分析レポート：展開モード別、最終用途別、地域別、セグメント別予測、2023年～2030年

Clinical Trials Matching Software Market Size, Share & Trends Analysis Report By Deployment Mode (Web & Cloud-based, On-premise), By End-use, By Region, And Segment Forecasts, 2023 - 2030

出版日
ページ情報
英文 90 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
臨床試験マッチングソフトウェアの市場規模、シェア、動向分析レポート：展開モード別、最終用途別、地域別、セグメント別予測、2023年～2030年
出版日: 2023年09月05日
発行: Grand View Research
ページ情報: 英文 90 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

臨床試験マッチングソフトウェア市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の臨床試験マッチングソフトウェア市場規模は2030年までに3億9,610万米ドルに達する見込みです。

2023年から2030年までのCAGRは13.2%で拡大する見込みです。進行中の臨床試験数の大幅な増加が市場を牽引するとみられます。また、臨床試験に対応する臨床試験マッチングソフトウェアの採用が増加していることや、ヘルスケア分野におけるバーチャル試験や自動化の需要が増加していることも、市場成長に寄与する主な要因の1つです。マッチングソフトウェアは、患者中心のアプローチで効果的かつ迅速な患者マッチングに役立ちます。

臨床試験では、患者のリクルートやマッチングに時間がかかり、適切なマッチングを見つけることが困難な場合があります。資格のある回答候補者のスクリーニングや検索、治験のあらゆる要素の検討、認知度の確認、参加へのインフォームド・コンセントの取得などは、患者募集中に考慮される要素です。資格要件に従って個人を採用することは極めて重要であり、それゆえ、特にCOVID-19のシナリオでは、トライアルマッチング技術が有用であることが証明されています。

このソフトウェアは、適切なマッチングを見つけるだけでなく、研究開発関連コストの節約にも役立ち、人手を介さずに円滑な運営を可能にしています。ソフトウェア・プロバイダーは、市場での地位を強化するために新しい革新的な技術を導入しています。例えば、2022年2月、CTMAはリウマチ領域におけるCT-SCOUT技術の提供を拡大しました。

臨床試験マッチングソフトウェア市場のレポートハイライト：

  • 展開モードに基づくと、ウェブおよびクラウドベースのセグメントが2022年の収益で市場を独占し、予測期間中に最も速いCAGRを記録すると予想されます。クラウド・コンピューティング・モデルは、メンテナンスや維持費が不要で、顧客は利用したサービスに対してのみ料金を支払えばよいです。一方、オンプレミスの導入には、社内インフラ、社内ITサポート、運転資金、高い統合コストがかかります。そのため、ウェブやクラウドベースのモデルが好まれます。
  • エンドユーズ別では、製薬企業およびバイオテクノロジー企業が、研究開発活動のコスト削減のため、進行中の臨床研究においてソフトウェアの導入が進んでいることから、2022年に最大の収益シェアを獲得しました。
  • CROの最終用途セグメントは、予測期間中に13.7%のCAGRで最も急速に拡大すると予測されています。CROは、臨床試験に必要な専門的支援、専門知識、実施経験を迅速に提供するため、スポンサーが専任の人材を雇用する必要はないです。CROのサービスは費用対効果、時間対効果が高いため、アウトソーシング先として好まれています。
  • 2022年、北米は製薬、バイオテクノロジー、医療関連企業による臨床試験マッチングソフトウェアの採用が増加しており、企業収益で市場をリードしました。
  • アジア太平洋地域は、患者/候補者の容易な募集をサポートする大規模な患者プールが利用可能であるため、予測期間中に最も速い成長率を記録すると予想されます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 臨床試験マッチングソフトウェア市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 普及と成長の見通しマッピング
  • 市場力学
    • 市場促進要因の分析
    • 市場抑制要因分析
  • 臨床試験マッチングソフトウェア市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 臨床試験マッチングソフトウェア：展開モードの推定と推定・動向分析

  • 臨床試験マッチングソフトウェア市場：重要なポイント
  • 臨床試験マッチングソフトウェア市場：動向と市場シェア分析、2022年および2030年
  • ウェブおよびクラウドベース
    • ウェブおよびクラウドベースの市場推計・予測、2018年から2030年まで
  • オンプレミス
    • オンプレミス市場推計・予測、2018年から2030年まで

第5章 臨床試験マッチングソフトウェア：最終用途推定・動向分析

  • 臨床試験マッチングソフトウェア市場：重要なポイント
  • 臨床試験マッチングソフトウェア市場：動向と市場シェア分析、2022年および2030年
  • 製薬およびバイオテクノロジー企業
  • CRO
  • 医療機器会社

第6章 臨床試験マッチングソフトウェア市場：地域推定・動向分析

  • 地域別の見通し
  • 地域別の臨床試験マッチングソフトウェア市場：マーケットプレースにおける重要なポイント
  • 北米
    • 市場推計・予測、2018～2030年
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • スウェーデン
    • ノルウェー
    • デンマーク
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 市場参入企業の分類
    • IBM Clinical Development
    • Antidote Technologies, INC.
    • Ofni Systems
    • Sss International Clinical Research
    • Clario
    • Advarra
    • Aris Global
    • Bsi Business Systems Integration Ag
    • Teckro
    • Clinical Trials Mobile Application
図表

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 3 North America clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 4 North America clinical trials matching software market, by region, 2018 - 2030 (USD Million)
  • Table 5 U.S. clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 6 U.S. clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 7 Canada clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 8 Canada clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 9 Europe clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 10 Europe clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 11 Europe clinical trials matching software market, by region, 2018 - 2030 (USD Million)
  • Table 12 Germany clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 13 Germany clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 14 UK clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 15 UK clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 France clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 17 France clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 18 Italy clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 19 Italy clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 20 Spain clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 21 Spain clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 Sweden clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 23 Sweden clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 24 Norway clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 25 Norway clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 26 Denmark clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 27 Denmark clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific clinical trials matching software market, by region, 2018 - 2030 (USD Million)
  • Table 31 China clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 32 China clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 33 Japan clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 34 Japan clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 35 India clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 36 India clinical trials matching software market, by end-use, (USD Million) 2018 - 2030
  • Table 37 Australia clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 38 Australia clinical trials matching software market, by end-use, (USD Million) 2018 - 2030
  • Table 39 Thailand clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 40 Thailand clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 South Korea clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 42 South Korea clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 43 Latin America clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 44 Latin America clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 45 Latin America clinical trials matching software market, by region, 2018 - 2030 (USD Million)
  • Table 46 Brazil clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 47 Brazil clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 48 Mexico clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 49 Mexico clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 Argentina clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 51 Argentina clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 52 Middle East and Africa clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 53 Middle East and Africa clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 54 Middle East and Africa clinical trials matching software market, by region, 2018 - 2030 (USD Million)
  • Table 55 South Africa clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 56 South Africa clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 UAE clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 60 UAE clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 61 Kuwait clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 62 Kuwait clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Clinical trials matching software: Market outlook
  • Fig. 9 Clinical trials matching software: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Clinical trials matching software market driver impact
  • Fig. 15 Clinical trials matching software market restraint impact
  • Fig. 16 Clinical trials matching software market strategic initiatives analysis
  • Fig. 17 Clinical trials matching software market: Deployment mode movement analysis
  • Fig. 18 Clinical trials matching software market: Deployment mode outlook and key takeaways
  • Fig. 19 Web & cloud-based market estimates and forecasts, 2018 - 2030
  • Fig. 20 On-premises market estimates and forecasts, 2018 - 2030
  • Fig. 21 Clinical trials matching software market: End-use movement analysis
  • Fig. 22 Clinical trials matching software market: End-use outlook and key takeaways
  • Fig. 23 Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 - 2030
  • Fig. 24 CROs market estimates and forecasts, 2018 - 2030
  • Fig. 25 Medical devices firms market estimates and forecasts, 2018 - 2030
  • Fig. 26 Global clinical trials matching software market: Regional movement analysis
  • Fig. 27 Global clinical trials matching software market: Regional outlook and key takeaways
  • Fig. 28 North America market estimates and forecasts, 2018 - 2030
  • Fig. 29 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 30 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 31 Europe. market estimates and forecasts, 2018 - 2030
  • Fig. 32 UK market estimates and forecasts, 2018 - 2030
  • Fig. 33 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 34 France market estimates and forecasts, 2018 - 2030
  • Fig. 35 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 36 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 37 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 38 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 39 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 40 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 41 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 42 China market estimates and forecasts, 2018 - 2030
  • Fig. 43 India market estimates and forecasts, 2018 - 2030
  • Fig. 44 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 45 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 46 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 47 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 48 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 49 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 50 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 51 Middle East and Africa. market estimates and forecasts, 2018 - 2030
  • Fig. 52 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 53 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 54 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 55 Kuwait market estimates and forecasts, 2018 - 2030
目次
Product Code: GVR-4-68039-921-8

Clinical Trials Matching Software Market Growth & Trends:

The global clinical trials matching software market size is expected to reach USD 396.1 million by 2030, based on a new report by Grand View Research, Inc.. It is expected to expand at a CAGR of 13.2% from 2023 to 2030. The significant increase in the number of ongoing clinical trials is likely to drive the market. In addition, the growing adoption of the clinical trial matching software catering to the clinical trials, along with the increased demand for virtual trials and automation in the healthcare sector are some of the key factors contributing to the market growth. The matching software help in effective and fast patient matching with patient-centric approaches.

In clinical trials, patient recruitment or matching can be time-consuming, and finding the right match can be a hurdle. Screening or locating prospective respondents who are qualified, considering all elements of the trials, verifying awareness, and getting informed consent to participate are the factors taken into consideration while recruiting patients. Enlisting the individuals in accordance with the qualifying requirements is crucial, hence the trial matching technology has been proved to be useful, especially in the COVID-19 scenario.

The software helps not only to find the right match but also saves the R&D-related costs, enabling smoother operations without human intervention. The software providers are introducing new innovative techniques to strengthen their market position. For instance, in February 2022, the CTMA expanded CT-SCOUT technology offering in rheumatology.

Clinical Trials Matching Software Market Report Highlights:

  • Based on deployment mode, the web and cloud based segment dominated the market in terms of revenue in 2022 and it is expected to register the fastest CAGR during the forecast period. The cloud computing models operate with no maintenance or upkeep charges and customers only have to pay for the services that are used. On the other hand, on-premises deployment involves in-house infrastructure, in-house IT support, working capital, and higher integration costs. Hence, web and cloud based models are preferred
  • Based on end use, pharmaceuticals and biotechnology companies captured the largest revenue share in 2022 owing to the higher adoption of software during ongoing clinical studies for cost-saving in the R&D activities
  • The CROs end-use segment is anticipated to expand at the fastest CAGR of 13.7% during the forecast period. CROs provide the professional assistance, expertise, and execution experience required for clinical trials quickly, without the need for the sponsor to engage such people full-time. CROs are preferred for outsourcing as their services are cost and time-effective
  • In 2022, North America led the market in terms of revenue owing to the rising adoption of the clinical trial matching software by the pharma, biotech, and medical companies in the region
  • Asia Pacific is anticipated to register the fastest growth rate over the forecast period due to the availability of a large patient pool supporting easy recruitment of patients/candidates

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Deployment Mode
    • 1.1.2. End-use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Deployment mode outlook
    • 2.2.2. End-use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Clinical Trials Matching Software Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Clinical Trials Matching Software Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic Landscape

Chapter 4. Clinical Trials Matching Software: Deployment Mode Estimates & Trend Analysis

  • 4.1. Clinical Trials Matching Software Market: Key Takeaways
  • 4.2. Clinical Trials Matching Software Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Web & Cloud-based
    • 4.3.1. Web & Cloud-Based market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. On-premises
    • 4.4.1. On-premises market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Clinical Trials Matching Software: End-use Estimates & Trend Analysis

  • 5.1. Clinical Trials Matching Software Market: Key Takeaways
  • 5.2. Clinical Trials Matching Software Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Pharmaceutical & Biotechnology Companies
    • 5.3.1. Pharmaceutical & Biotechnology Companies market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. CROs
    • 5.4.1. CROs market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Medical Device Firms
    • 5.5.1. Medical Device Firms market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Clinical Trials Matching Software Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Clinical Trials Matching Software Market by Region: Key Marketplace Takeaway
  • 6.3. North America
    • 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. France
      • 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Sweden
      • 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Norway
      • 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. China
      • 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.3. India
      • 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Mexico
      • 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. Saudi Arabia
      • 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. IBM Clinical Development
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Antidote Technologies, INC.
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Ofni Systems
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Sss International Clinical Research
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. Clario
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Advarra
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. Aris Global
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Bsi Business Systems Integration Ag
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. Teckro
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. Clinical Trials Mobile Application
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Product benchmarking
      • 7.2.10.4. Strategic initiatives